Enveda company information, Employees & Contact Information

Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors Business Wire

Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M Yahoo Finance

Enveda raises $130M series C to take more AI-discovered compounds into the clinic Fierce Biotech

Using AI to unlock nature’s hidden pharmacy Springwise

Enveda adds millions to Series C haul BizWest

Enveda raises $130m to advance AI-driven plant based drug development Pharmaceutical Technology

Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates Business Wire

Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board Yahoo Finance

A drug discovery startup banks $150M for immune and obesity drugs BioPharma Dive

Enveda Therapeutics’ Gets a $130M Boost for Eczema Research autogpt.net

Enveda Biosciences Collaborates with Microsoft to Unveil PRISM: Revolutionizing Drug Discovery with AI SynBioBeta

Enveda raises $55M to combine ancient remedies with AI for drug discovery TechCrunch

Enveda collects another $150M for I&I drug, sprawling pipeline of preclinical assets Endpoints News

With Mother Nature as its lead chemist, Enveda clinches another $150M FirstWord Pharma

Enveda harvests another $150M to advance nature-inspired drugs Fierce Biotech

Enveda Welcomes Jason Kim as Chief Financial Officer Business Wire

Enveda Secures $150M in Series D Funding, Enrolls First Patient in Lead Program, Welcomes Mikael Dolsten to Board SynBioBeta

Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials Business Wire

Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials Business Wire

Enveda Biosciences Announces Microsoft Collaboration and Reveals Foundation Model to “Read and Translate” Chemistry Business Wire

Sanofi backs Enveda's AI-plus-nature approach to drug discovery FirstWord Pharma

Enveda Biosciences Hires Chief Medical Officer to Advance Its Rich Pipeline of Therapeutic Programs into the Clinic Business Wire

Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate Genetic Engineering and Biotechnology News

Enveda bags $130M to harness plant-derived molecules for AI drug innovation FirstWord Pharma

Enveda Biosciences raises $130M to advance AI-driven drug discovery from natural compounds SiliconANGLE

Enveda further accelerates atopic dermatitis drive with financing The Pharma Letter

Enveda Reports Favorable Phase 1 Safety for Novel Oral Anti-Inflammatory, Launches Phase 1b Trial in Atopic Dermatitis BioSpace

Enveda Biosciences Closes $68-million Combined Series B Equity and Debt Financing Business Wire

AI Drug Discovery Startup Enveda Raises $130 Million Bloomberg.com

Enveda’s Matured Platform Drives Toward Three INDs in 2023 BioSpace

Enveda Biosciences Announces Oversubscribed Series B1 Bringing Total Round to US$119 Million Business Wire

Enveda raises $150M for drug development, hits unicorn status Axios

Enveda Raises $150M in Series D Funding FinSMEs

Enveda Biosciences The Pharma Letter

Enveda Raises $150 Million, Hits Unicorn Status, Begins Lead Trial, Adds Pfizer's Dolsten to Board INDIA New England News

Enveda Biosciences appoints industry leader Mark Deeg, M.D., Ph.D., as Chief Medical Officer Business Wire

Exclusive: Enveda Biosciences Announces $4.9M Seed To Create Medicinal Plant Database Crunchbase News

Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital Business Wire

Enveda Biosciences to Open Advanced Drug Discovery and Development Center in Boulder, Colo.; Lead Optimization Laboratory in Hyderabad, Telangana, India Business Wire